Less chemotherapy works well for some childhood cancer
A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
University of California San Francisco
Give to UCSFA particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
UCSF research-doctorate programs have ranked among the nation’s best in a survey released today by the National Research Council (NRC).
Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.
The U.S. Department of Justice declined to consent to the University of California’s motion to intervene in Sherley v. Sebelius, the case regarding federal funding for human embryonic stem cell (hESC) research, on which UC had made a motion to the U.S. Federal Court of Appeals on Sept. 20.
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.
Renown Institute for Cancer in Reno and the UCSF Helen Diller Family Comprehensive Cancer Center, the two leading cancer programs in their regions, have joined forces to enhance patient care and improve access to top level medical experts.
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.
The UCSF Diabetes Center will celebrate a decade of advancing research and patient care in diabetes with a scientific symposium featuring the nation’s leaders in the field.
An inexpensive, hundred-year-old therapy for pain – aspirin – is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center.
Cell biologists at UCSF have received $15.4 million from the National Institutes of Health to set up one of two new National Centers for Systems Biology, to study how cells respond to their environment – an emerging field of research that could revolutionize medicine by creating “smart cells” to deliver medications and other therapeutics more effectively.
The University of California filed a motion Sept. 20 with the U.S. Federal Court of Appeals to intervene in Sherley v. Sebelius, the case regarding whether federal funds could be used for human embryonic stem cell (hESC) research. UC is the nation’s first research institution to formally seek to intervene in the pending lawsuit.
The University of California Board of Regents today unanimously approved funding plans for the new UCSF Medical Center at Mission Bay, clearing the way for UCSF to break ground on a world-class hospital complex for children, women and cancer patients in the Mission Bay neighborhood south of downtown San Francisco.
A method that is widely used to predict the risk of a major coronary event may over- or underestimate risk for millions of Americans, according to a study directed by a researcher at the San Francisco VA Medical Center and the University of California, San Francisco.
UCSF scientists will receive two grants totaling $15.1 million over the next five years to expand their research into how genes affect an individual’s response to medication and to strengthen a global network of researchers involved in these efforts.
UCSF researchers today unveiled a prototype model of the first implantable artificial kidney, in a development that one day could eliminate the need for dialysis.
Ezlopitant, a compound known to suppress craving for alcohol in humans, was shown to decrease consumption of sweetened water by rodents in a study by researchers at the Ernest Gallo Clinic and Research Center, which is affiliated with UCSF.
A celebration of the Zen Hospice Project’s Guest House re-opening and new partnership with UCSF Medical Center.
In a study of elderly Americans who moved to a nursing home for their final months or years of life, 80 percent died there within one year, according to an investigation by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
A joint project of UCSF and the Kenya Medical Research Institute has received $7 million—the first award of a five year grant that will total about $35 million—to expand its care and support of people affected by HIV/AIDS in Kenya.
The oil spill along the United States Gulf Coast poses health risks to volunteers, fishermen, clean-up workers and members of coastal communities, according to a new commentary by UCSF researchers who spent time in the region and are among the first to look into health problems caused by the oil spill. The good news, the authors say, is that one of the risk factors, coastal air quality, is improving now that the oil leak has been stopped.
A UCSF-led team has discovered at least one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia.
Obesity rates have started to decline and level off for many adolescents, but continue to increase for certain racial and ethnic minorities, according to a new UCSF-led study.
Specialists in geriatric medicine at the San Francisco VA Medical Center and the VA Connecticut Healthcare System call the traditional approach of advance care planning “fundamentally flawed,” and propose a new paradigm.
A mutation found in a mouse gene that also appears in humans might provide new insights into the genetic roots of alcoholism, according to a study led by researchers at the Ernest Gallo Clinic and Research Center and UCSF. The study appears in the August 12, 2010, edition of “<i>PLoS Genetics</i>.”
In neurodegenerative diseases, clumps of insoluble proteins appear in patients’ brains. These aggregates contain proteins that are unique to each disease, such as amyloid beta in Alzheimer’s disease, but they are intertwined with small amounts of many other insoluble proteins that are normally present in a soluble form in healthy young individuals.
A UCSF-led team has discovered a direct link between an inherited genetic mutation, a set of developmental abnormalities and a rare form of childhood leukemia called juvenile myelomonocytic leukemia, or JMML.
UCSF researchers are reporting the first success in very rapidly purifying one type of embryonic stem cell from a mix of many different types of embryonic stem cells in the culture dish. The technique, which avoids the need to genetically alter the cells to distinguish them, is a key advance, the researchers say, for obtaining the appropriate cells for repairing specific damaged tissues.
Surgery for localized prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study led by researchers at UCSF.
Hospital emergency departments need to be better adapted to the needs of terminally ill patients who are increasingly seeking palliative care in the emergency room, according to a study led by a physician at the San Francisco VA Medical Center.
UCSF Benioff Children's Hospital will celebrate children and their families at the 15th annual Pediatric Transplant Picnic.